High Court Considers Drug Sales Reps' OT Status

Law360, New York (April 16, 2012, 7:40 PM EDT) -- The U.S. Supreme Court on Monday grilled attorneys for GlaxoSmithKline PLC, its sales representatives and the government about whether the proposed class of reps is entitled to overtime pay and how much deference the court should give the U.S. Department of Labor's amicus brief arguments that it is.

The justices asked tough questions of all three attorneys at oral arguments on whether the Fair Labor Standards Act's outside sales exemption applies to the sales reps, who are legally prohibited from closing sales but whom the pharmaceutical...
To view the full article, register now.